Open menu

Nanotechnology General News

The latest news from academia, regulators
research labs and other things of interest

Posted: June 15, 2009

Canadian synchrotron conference sheds light on new nanotechnology and biomedical research

(Nanowerk News) Science fact surpasses science fiction at the Canadian Light Source (CLS) synchrotron's 12th Annual Users' Meeting Thursday, June 18 at the Radisson Hotel in Saskatoon. Conference participants will hear about some of the newest biomedical results from the CLS, as well as ways that synchrotron techniques are lighting the way to advances in environmental clean up and nanotechnology.
Highlights include:
  • Presentations by CLS users on using the synchrotron to study esophageal tumours, prion diseases such as BSE, watch nerves regenerate and treat tuberculosis
  • Applications of synchrotron techniques to agricultural research, developing bioproducts and bioremediation
  • Studying nanomaterials and materials at extreme conditions
  • Science fact is preceded by a free public lecture "Science Fiction as a Mirror for Reality" by internationally renowned science fiction author and CLS writer-in-residence Robert J. Sawyer on Wednesday, June 17 at 7 pm at the Frances Morrison Library Theatre.
    For more information, visit:
    The Canadian Light Source is Canada's national centre for synchrotron research. Located at the University of Saskatchewan in Saskatoon, the CLS is a powerful tool for academic and industrial research in a wide variety of areas including environmental science, natural resources and energy, health and life sciences, and information and communications technology. CLS operations are funded by the Government of Canada, NSERC, NRC, CIHR, the Government of Saskatchewan and the University of Saskatchewan.
    Source: Canadian Light Source
    Subscribe to a free copy of one of our daily
    Nanowerk Newsletter Email Digests
    with a compilation of all of the day's news.
    If you liked this article, please give it a quick review on reddit or StumbleUpon. Thanks!
    These articles might interest you as well: